| 2024-05 |
Earliest total vascular damage index scores independently predict all-cause mortality in patients with ANCA-associated vasculitis |
Clinical and Experimental Rheumatology
|
| 2024-05 |
Overlap syndrome of systemic sclerosis with antineutrophil cytoplasmic antibody-associated vasculitis according to 2022 ACR/EULAR criteria |
The Korean Journal of Internal Medicine
|
| 2024-04 |
Chemokine expression in sera of patients with microscopic polyangiitis and granulomatosis with polyangiitis |
Scientific Reports
|
| 2024-04 |
Presence of periodontal disease and the incidence of inflammatory arthritides in the general population: data from the UK Biobank |
Rheumatology
|
| 2024-03 |
New-onset atrial fibrillation in seropositive rheumatoid arthritis: association with disease-modifying anti-rheumatic drugs treatment |
Rheumatology
|
| 2024-02 |
Circulating cold-inducible RNA-binding protein levels in microscopic polyangiitis and granulomatosis with polyangiitis |
Zeitschrift für Rheumatologie
|
| 2024-02 |
Birmingham vasculitis activity score and the short form 36-item health survey predict current depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis during the SARS-CoV-2 pandemic |
Zeitschrift für Rheumatologie
|
| 2024-02 |
Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort |
Seminars in Arthritis and Rheumatism
|
| 2024-01 |
Antineutrophil cytoplasmic antibody‑associated vasculitis classification by cluster analysis based on clinical phenotypes: a single‑center retrospective cohort study |
Clinical Rheumatology
|
| 2024-01 |
Association Between Decreased Renal Function and Pulmonary Function Decline in Community-dwelling Adults |
In Vivo
|
| 2024-01 |
Renal prognosis in patients with new-onset microscopic polyangiitis and granulomatosis with polyangiitis requiring dialysis and potential predictor of renal function recovery |
대한류마티스학회지
|
| 2023-12 |
Clinical implications of peripheral eosinophil count at diagnosis in patients newly diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis |
Arthritis Research & Therapy
|
| 2023-11 |
IL-6 Receptor Expression on the Surface of T Cells and Serum Soluble IL-6 Receptor Levels in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis |
Journal of Clinical Medicine
|
| 2023-10 |
Soluble triggering receptor expressed on myeloid cell-1 reflects the cross-sectional activity of microscopic polyangiitis and granulomatosis with polyangiitis |
Heliyon
|
| 2023-10 |
Vasculitis Activity-Predicting Ability of IL-12 Family Cytokines in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis |
Yonsei Medical Journal
|
| 2023-09 |
A new index for distinguishing hypereosinophilic syndrome and antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis |
Asian Pacific Journal of Allergy and Immunology
|
| 2023-09 |
Renal histopathological predictors of end‑stage kidney disease in ANCA‑associated vasculitis with glomerulonephritis: a single‑centre study in Korea |
Scientific Reports
|
| 2023-09 |
Association between computed tomography-assessed sarcopenia and mortality in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis |
International Journal of Rheumatic Diseases
|
| 2023-09 |
Cancers and cardiovascular diseases in patients with seropositive rheumatoid arthritis treated with JAK inhibitors, biologics and conventional synthetic DMARDs |
Clinical and Experimental Rheumatology
|
| 2023-08 |
Incidence of septic arthritis in patients with ankylosing spondylitis and seropositive rheumatoid arthritis following TNF inhibitor therapy |
Rheumatology
|
| 2023-08 |
Acute Brain Infarction in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis A Korean Single-Center Study |
Journal of Clinical Rheumatology
|
| 2023-08 |
A prognostic immune nutritional index can predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
Therapeutic Advances in Musculoskeletal Disease
|
| 2023-07 |
Risk of cancer, tuberculosis and serious infections in patients with ankylosing spondylitis, psoriatic arthritis and psoriasis treated with IL-17 and TNF-α inhibitors: a nationwide nested case-control analysis |
Clinical and Experimental Rheumatology
|
| 2023-06 |
Total Globulin Fraction at Diagnosis Could Forecast All-Cause Mortality during the Disease Course in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
Journal of Clinical Medicine
|
| 2023-05 |
New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
Frontiers in Medicine
|
| 2023-05 |
Predictive potential of albumin-alkaline phosphatase ratio for cerebrovascular accident in patients with antineutrophil cytoplasmic antibody–associated vasculitis |
Annals of Clinical Biochemistry
|
| 2023-04 |
Soluble Tyro-3 and Axl may reflect the current activity and renal involvement in patients with microscopic polyangiitis and granulomatosis with polyangiitis |
Clinical and Experimental Rheumatology
|
| 2023-04 |
Serum soluble interleukin-7 receptor alpha levels are negatively correlated with the simultaneous activity of antineutrophil cytoplasmic antibody-associated vasculitis |
Clinical and Experimental Rheumatology
|
| 2023-04 |
Application of the 2022 ACR/EULAR criteria for microscopic polyangiitis to patients with previously diagnosed microscopic polyangiitis |
Clinical and Experimental Rheumatology
|
| 2023-04 |
Management of antineutrophil cytoplasmic antibody-associated vasculitis: a review of recent guidelines |
Journal of Rheumatic Diseases
|
| 2023-03 |
Reclassification of previously diagnosed GPA patients using the 2022 ACR/EULAR classification criteria |
Rheumatology (United Kingdom)
|
| 2023-02 |
Positive faecal immunochemical test predicts the onset of inflammatory bowel disease: A nationwide, propensity score-matched study |
Frontiers in Immunology
|
| 2023-02 |
The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis |
Journal of Rheumatology
|
| 2023-01 |
Cancer‑associated vasculitides: a single‑centre case series |
Clinical Rheumatology
|
| 2022-12 |
Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
Scientific Reports
|
| 2022-11 |
Clinical impact of proteinase 3-antineutrophil cytoplasmic antibody positivity in eosinophilic granulomatosis with polyangiitis |
Korean Journal of Internal Medicine
|
| 2022-11 |
Interferon-gamma Release Assay Results Are Reliable for Screening for Latent Tuberculosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis |
In Vivo
|
| 2022-11 |
BVAS version 3 and BVAS/GPA: standing on the same line? |
CLINICAL RHEUMATOLOGY
|
| 2022-10 |
Clinical impact of antineutrophil cytoplasmic antibody positivity on the occurrence of interstitial lung disease in patients with polymyositis/dermatomyositis |
Annals of Palliative Medicine
|
| 2022-08 |
Serum glycated albumin as a predictive biomarker for renal involvement of antineutrophil cytoplasmic antibody‑associated vasculitis in non‑diabetic patients |
BMC NEPHROLOGY
|
| 2022-08 |
Assessment of disease activity in patients with rheumatoid arthritis using plasma tumour M2-pyruvate kinase test |
FRONTIERS IN IMMUNOLOGY
|
| 2022-07 |
Modified Body Mass Index at Diagnosis is a Useful Predictor of Mortality in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis |
Journal of Rheumatic Diseases
|
| 2022-07 |
Nutrition Risk Index Score at Diagnosis Can Effectively Predict Poor Prognosis in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
JOURNAL OF RENAL NUTRITION
|
| 2022-07 |
Predicting the depressive status using empirical dietary inflammatory index in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
JOURNAL OF CLINICAL LABORATORY ANALYSIS
|
| 2022-07 |
Serum albumin, prealbumin, and ischemiamodified albumin levels in patients with ANCA-associated vasculitis: A prospective cohort study |
PLOS ONE
|
| 2022-07 |
Secular Trends of Incidence, Prevalence, and Healthcare Economic Burden in ANCA-Associated Vasculitis: An Analysis of the 2002–2018 South Korea National Health Insurance Database |
Frontiers in medicine
|
| 2022-07 |
A positive faecal immunochemical test result and its association with the incidence of rheumatoid arthritis, systemic lupus erythematosus, and psoriatic arthritis: an analysis of one-million national colorectal cancer screening programme results |
BMC MEDICINE
|
| 2022-06 |
Fatty Liver Index Independently Predicts All-Cause Mortality in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis but No Substantial Liver Disease |
FRONTIERS IN CARDIOVASCULAR MEDICINE
|
| 2022-06 |
Triglyceride and Glucose Index Predicts Acute Coronary Syndrome in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
Diagnostics
|
| 2022-06 |
Association of serum hepatoma-derived growth factor levels with disease activity in rheumatoid arthritis: A pilot study |
JOURNAL OF CLINICAL LABORATORY ANALYSIS
|
| 2022-05 |
Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single- Centre Observational Study |
JOURNAL OF IMMUNOLOGY RESEARCH
|
| 2022-05 |
New body mass index for predicting prognosis in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
JOURNAL OF CLINICAL LABORATORY ANALYSIS
|
| 2022-05 |
Serum galectin-9 could be a potential biomarker in assessing the disease activity of antineutrophil cytoplasmic antibody-associated vasculitis |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
|
| 2022-05 |
Effect of numbers of metabolic syndrome components on mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis with metabolic syndrome |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
|
| 2022-04 |
Incidence, prevalence and risk of stroke in patients with Takayasu arteritis: a nationwide population-based study in South Korea |
Stroke and Vasular Neurology
|
| 2022-04 |
Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
Medicina (Kaunas, Lithuania)
|
| 2022-04 |
Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander? |
RHEUMATOLOGY
|
| 2022-04 |
Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experience |
LUPUS
|
| 2022-04 |
Clinical Features of Anti-Synthetase Syndrome Associated with Prognosis in Patients with Dermatomyositis and Polymyositis |
Journal of Clinical Medicine
|
| 2022-03 |
Aortic valve surgery in patients with Takayasu’s arteritis: a nationwide analysis of 1,197 patients during a 9-year period |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
|
| 2022-03 |
A retrospective analysis of antineutrophil cytoplasmic antibodyassociated vasculitis aiming for an equation prediction end-stage renal disease |
CLINICAL RHEUMATOLOGY
|
| 2022-02 |
Serum vitamin D level correlates with disease activity and healthrelated quality of life in antineutrophil cytoplasmic antibody-associated vasculitis |
ZEITSCHRIFT FUR RHEUMATOLOGIE
|
| 2022-01 |
Association Between Idiopathic Cutaneous Leukocytoclastic Angiitis and ANCA-negative Microscopic Polyangiitis |
Journal of Rheumatic Diseases
|
| 2021-12 |
Metabolic Syndrome Severity Score, Comparable to Serum Creatinine, Could Predict the Occurrence of End-Stage Kidney Disease in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
Journal of Clinical Medicine
|
| 2021-11 |
Serum progranulin as a predictive marker for high activity of antineutrophil cytoplasmic antibody-associated vasculitis |
JOURNAL OF CLINICAL LABORATORY ANALYSIS
|
| 2021-10 |
Clinical significance of large unstained cell count in estimating the current activity of antineutrophil cytoplasmic antibody-associated vasculitis |
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
|
| 2021-09 |
Efficacy of tacrolimus as maintenance therapy after cyclophosphamide for treating antineutrophil cytoplasmic antibody-associated vasculitis |
MEDICINE
|
| 2021-08 |
Systemic inflammation response index predicts all‑cause mortality in patients with antineutrophil cytoplasmic antibody‑associated vasculitis |
INTERNATIONAL UROLOGY AND NEPHROLOGY
|
| 2021-07 |
Significance of antineutrophil cytoplasmic antibody positivity in patients with systemic sclerosis: a single-centre pilot study in Korea |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
|
| 2021-06 |
The Efficacy of Mycophenolate Mofetil in Remission Maintenance Therapy for Microscopic Polyangiitis and Granulomatosis with Polyangiitis |
YONSEI MEDICAL JOURNAL
|
| 2021-05 |
Male Sex Is a Significant Predictor of All-cause Mortality in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis |
JOURNAL OF KOREAN MEDICAL SCIENCE
|
| 2021-04 |
Total Haemolytic Complement Activity at Diagnosis as an Indicator of the Baseline Activity of Antineutrophil Cytoplasmic Antibody-associated Vasculitis |
대한류마티스학회지
|
| 2021-04 |
Fibrinogen to albumin ratio reflects the activity of antineutrophil cytoplasmic antibody-associated vasculitis |
JOURNAL OF CLINICAL LABORATORY ANALYSIS
|
| 2021-04 |
The novel fibrosis index at diagnosis may predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis without substantial liver diseases |
CLINICS
|
| 2021-04 |
Efficacy of the fibrosis index for predicting end-stage renal disease in patients with antineutrophil cytoplasmic antibodyassociated vasculitis |
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
|
| 2021-03 |
Pan-immune-inflammation value at diagnosis independently predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
|
| 2021-03 |
Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
| 2021-01 |
Serum Granzyme B is associated with otorhinolaryngological, pulmonary, and renal involvement of antineutrophil cytoplasmic antibody-associated vasculitis |
JOURNAL OF INVESTIGATIVE MEDICINE
|
| 2020-04 |
Serum interleukin-16 significantly correlates with the Vasculitis Damage Index in antineutrophil cytoplasmic antibodyassociated vasculitis |
ARTHRITIS RESEARCH & THERAPY
|
| 2020-03 |
Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study |
CLINICAL RHEUMATOLOGY
|
| 2020-01 |
Clinical implication of chronic paranasal sinusitis for the classification of microscopic polyangiitis |
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
|
| 2019-12 |
Controlling Nutritional Status Score is Associated with All-Cause Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
YONSEI MEDICAL JOURNAL
|
| 2019-12 |
Predictor of depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
CLINICAL RHEUMATOLOGY
|
| 2019-11 |
Risk of Cancers in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results from the Korea National Health Insurance Claims Database 2010–2018 |
Journal of Clinical Medicine
|
| 2019-11 |
Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice |
BIOMATERIALS
|
| 2019-07 |
Persistent antiphospholipid antibodies are associatedwith thrombotic events in ANCA-associated vasculitis:A retrospective monocentric study |
NEFROLOGIA
|
| 2019-06 |
Serum interleukin-21 positivity could indicate the current activity of antineutrophil cytoplasmic antibody-associated vasculitis: a monocentric prospective study |
CLINICAL RHEUMATOLOGY
|
| 2019-05 |
Serum Aminoacyl-tRNA Synthetase-Interacting Multifunctional Protein-1 Can Predict Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Pilot Monocentric Study |
BIOMED RESEARCH INTERNATIONAL
|
| 2019-05 |
Should nasal biopsy inevitably be performed for classifying granulomatosis with polyangiitis in patients with rhinosinusitis? A retrospective chart review study |
RHEUMATOLOGY INTERNATIONAL
|
| 2019-04 |
No overlap between IgG4-related disease and microscopic polyangiitis and granulomatosis with polyangiitis despite elevated serum IgG4 at diagnosis: a retrospective monocentric study |
CLINICAL RHEUMATOLOGY
|
| 2019-03 |
Serum soluble programmed cell death protein 1 could predict the current activity and severity of antineutrophil cytoplasmic antibody-associated vasculitis: a monocentric prospective study |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
|
| 2019-02 |
Clinical role of albumin to globulin ratio in microscopic polyangiitis: a retrospective monocentric study |
CLINICAL RHEUMATOLOGY
|